C1 esterase inhibitor recombinant Intravenous and Xultophy
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Xultophy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy 100/3.6
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Xultophy 100/3.6
- C1 esterase inhibitor recombinant Intravenous-Xuriden
- C1 esterase inhibitor recombinant Intravenous-Xylocaine
- C1 esterase inhibitor recombinant Intravenous-Xylocaine (Cardiac)
- C1 esterase inhibitor recombinant Intravenous-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- C1 esterase inhibitor recombinant Intravenous-Xylocaine (Lidocaine Oral Liquid and Solution)
- Xultophy-C1 esterase inhibitor, human Intravenous
- Xultophy-C1 Inhibitor (Human)
- Xultophy-C1 Inhibitor (Human) (Berinert)
- Xultophy-C1 Inhibitor (Human) (Cinryze)
- Xultophy-C1 Inhibitor (Human) (Haegarda)
- Xultophy-C1 Inhibitor (Recombinant)